课题基金 / 基金详情

Pathogenesis of Lupus Nephritis

Pathogenesis of Lupus Nephritis
狼疮性肾炎的发病机制
批准号:
10159199
负责人:
Joseph Edgar Craft
金额:
$61.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-06 至 2025-04-30

项目摘要

项目成果

Joseph Edgar Craft的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (ABSTRACT) Lupus nephritis occurs in a majority of patients with systemic lupus erythematosus (SLE, lupus), and is a leading cause of morbidity and mortality. CD4+ and CD8+ T effector cells contribute to the inflammatory response in lupus nephritis in mice and in humans with their renal infiltration correlated to tissue damage and disease severity. Yet, there is limited knowledge of the phenotypic characteristics of the T cells that promote local tissue injury in lupus. The kidney microenvironment becomes hypoxic as a common denominator following a variety of insults, an appropriately physiologic response analogous to that which occurs to ensure lymphocyte survival and effector function during environmental stress, such as at sites of pathogen replication or in tumors. We have shown in preliminary studies that this response in the murine lupus kidney results in tissue adaptive transcriptional and phenotypic changes in renal infiltrating T cells, changes associated with epigenetic modification, with evidence that analogous changes occur in human lupus nephritis. We now propose in this revised application sto explore the hypothesis that environmental stress in the lupus kidney necessarily shapes the phenotypes of renal-infiltrating T cells, with programming for survival and effector function, culminating in tissue injury. We will explore this hypothesis using in vitro and in vivo studies, including genetic and pharmacologic manipulation of tissue adaptive effector pathways in renal T cells, with target confirmation in human lupus nephritis. Our longer term goal, if the current project is successful, is to use this knowledge to re-purpose therapeutic agents currently available for use in humans to treat lupus nephritis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel Lyme disease vaccine
  • 批准号:
    10515700
  • 项目类别:
  • 资助金额:
    $64.81万
  • 财政年份:
    2022
  • 负责人:
    Joseph Edgar Craft
  • 依托单位:
A novel Lyme disease vaccine
  • 批准号:
    10640164
  • 项目类别:
  • 资助金额:
    $64.81万
  • 财政年份:
    2022
  • 负责人:
    Joseph Edgar Craft
  • 依托单位:
Human and Translational Immunology Training Program
  • 批准号:
    10649548
  • 项目类别:
  • 资助金额:
    $42.43万
  • 财政年份:
    2021
  • 负责人:
    Joseph Edgar Craft
  • 依托单位:
Human and Translational Immunology Training Program
  • 批准号:
    10270035
  • 项目类别:
  • 资助金额:
    $42.32万
  • 财政年份:
    2021
  • 负责人:
    Joseph Edgar Craft
  • 依托单位:
海外基金